about
Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.Diet restriction increases ubiquinone contents and inhibits progression of hepatocellular carcinoma in the ratStructure and liver cell expression pattern of the HFE gene in the ratIncreased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms.Reverse lectin ELISA for detecting fucosylated forms of α1-acid glycoprotein associated with hepatocellular carcinoma.Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease.Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study.SAF score and mortality in NAFLD after up to 41 years of follow-up.Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.Quantitative determination of 8-hydroxy-2'-deoxyguanosine in human urine by isotope dilution mass spectrometry: normal levels in hemochromatosis.Expression of autoantibodies to specific cytochromes P450 in a case of disulfiram hepatitis.DNA adducts in normal colonic mucosa from healthy controls and patients with colon polyps and colorectal carcinomas.A novel mutation in the biliverdin reductase-A gene combined with liver cirrhosis results in hyperbiliverdinaemia (green jaundice).Expression of thioredoxins and glutaredoxins in human hepatocellular carcinoma: correlation to cell proliferation, tumor size and metabolic syndrome.In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma.Digital ambulatory monitoring of small-bowel motility.Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?[Life-saving transplantation in pregnancy-related liver failure. Well functioning care continuity contributed to the good result].Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up.Validation of a competitive ELISA assay for the quantification of human serum hepcidin.Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver DiseaseEvaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis[Elastography--a new tool for diagnosis of chronic liver diseases. Might replace liver biopsy, but not always]HFEmutations in patients with hereditary haemochromatosis in SwedenRisk of ischaemic heart disease and cardiomyopathy in patients with haemochromatosis and in their first-degree relatives: a nationwide, population-based studyLiver transplantation for erythropoietic protoporphyria in europeIron increases ethanol toxicity in rat liverHepatotoxicity induced by iron overload and alcohol. Studies on the role of chelatable iron, cytochrome P450 2E1 and lipid peroxidationKupffer cell iron overload induces intercellular adhesion molecule-1 expression on hepatocytes in genetic hemochromatosisThe effects of dietary iron on initiation and promotion in chemical hepatocarcinogenesis[Tips about new discoveries on TIPS. Better and better treatment of portal hypertension and esophageal and gastric varices]Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinomaStudies on genotoxic effects of iron overload and alcohol in an animal model of hepatocarcinogenesis[Hepatitis GBV isolated in acute liver failure. Successful outcome after liver transplantation]
P50
Q26780252-7CE1BCE0-88D2-4C28-8C89-F6703EAB653BQ28370416-62840C35-A460-4940-8001-AB0F94801747Q28570163-AE66BF16-4C48-48E5-B9D8-6F074018A222Q30238749-29FF7C22-4C77-4CD5-BCCB-A7CE1B3C6A8DQ35595107-BF720337-6E28-4873-ACC5-F739B3AADA1EQ36218142-E9993231-028C-4235-8E65-FFBE07558134Q36309104-4ADACD73-B373-4FB8-BD3A-6714B92FCC63Q38447369-92BC0BFC-8B90-4A2F-B162-A549DA7D8A4BQ38799485-30A0FD57-0C01-4D04-8382-7E6E4DB4865EQ38986591-2FCD46EE-BE2D-4F67-A436-D7CBBDB29F7DQ39402697-155A7F6C-4561-4542-90BF-C49E3F5069B8Q40084558-A5F9A216-389E-4A0F-847C-DB5EDD616F3FQ41027031-E47D7112-2DD5-4286-BCDB-8354BABE44E4Q42201783-336B5696-8960-4F9E-839D-FE8D3F7FB051Q42536749-D6FD1AC2-BB00-4621-A6FF-35CD0A62AC52Q42537961-C22CCF74-FEAD-4999-82C5-FEBBCF6E7E10Q43020722-D13AB19F-CA48-4029-B7C2-EA5BF7020354Q45938287-D77AFA80-4201-49C8-995E-3BE8E119135CQ47450184-3A63BD43-1D76-4D49-8E0F-5053AE1A7D60Q48134140-B9E09E16-C4BC-4128-A7E6-7CF445556F52Q48609483-EA91E927-81E9-4352-88F5-5E36CF117665Q50599978-14E20404-3219-451F-8DF9-0127CD8CECD3Q50787922-CDF9EEFE-CEB4-4F06-9F96-A8B214CA3E6BQ53125994-43E9EDC1-714A-488F-AB98-58382AD924B5Q53791053-84F4ED14-6E4D-4AA6-B614-6AE3FB175DAEQ55222045-95A51143-CFE4-487C-BB17-A41AA9849602Q57177422-8014D3A3-FBC3-403D-B26E-A687F7C5589FQ57568878-D510BC15-B3F0-4CB9-86C9-ECEF5BDC7A92Q59490149-30266400-A20E-48F2-A7F6-BDEA2A1A26EBQ60906180-B88B223D-4415-4323-8035-EDFBE018E262Q61280572-24824B9F-5934-47C4-AE78-DA8BA8E0E63FQ61796585-FDA1EB86-533D-4E27-ADAD-8A8A6F9AF269Q70590193-194B9A12-7EED-4CD2-A888-20526C7D4FB9Q71766360-44DD8097-C7F2-4535-AD03-DCDCCAA3D46AQ72210555-96A245EF-7B75-47FC-9CF6-2F671E036109Q72511357-0095F497-BAFB-4786-80DA-22CE9FDCF715Q72898538-61F23620-ACFD-4086-AA62-F9EBFCB3A396Q73419412-CA49CEDA-92FA-446D-87BC-B0193AFC6A54Q73740633-8BD4BCD7-31A3-4087-92EF-D6C0CAB26F0FQ73971906-7AC56935-423F-49E2-A282-B80903C62FB3
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Per Stål
@en
Stål P
@ast
Stål P
@es
Stål P
@nl
type
label
Per Stål
@en
Stål P
@ast
Stål P
@es
Stål P
@nl
altLabel
Stål P
@en
prefLabel
Per Stål
@en
Stål P
@ast
Stål P
@es
Stål P
@nl
P31
P496
0000-0003-2915-1964